360 Stem Cell & Regenerative Medicine Newsletter - Oct 01, 2014

 weSRCH's Best of the Internet Award

360 Stem Cell & Regenerative Medicine Newsletter - Oct 01, 2014

Featured video from ClinicalNews.org : Turmeric compound boosts regeneration of brain stem cells
Turmeric compound boosts regeneration of brain stem cells
Pass the yellow mustard! Turmeric compound boosts regeneration of brain stem cells. Lead author of the study, Adele Rueger, said: “While several substances have been described to promote stem cell proliferation in the brain, fewer drugs additionally promote the differentiation of stem cells into neurons, which constitutes a major goal in regenerative medicine. Our findings on aromatic turmerone take us one step closer to achieving this goal.”

GEN: Stem cell peaks yet unscaled- previews upcoming World Stem Cell Summit
In a featured article, GEN journalist Vicki Glaser covers some of the wide-ranging topics at the upcoming World Stem Cell Summit in San Antonio. Emerging topics include complexities of managing the production of a stem cell product, improvements in the current publication model, differentiating stem cells to obtain specific cell types related to a disease and using microRNA (miRNA) profiles to predict potential clinical outcomes. Dr. Evan Snyder, Dr. Graham Parker, Dr. Mary Pat Moyer (INCELL) and Jim Reid (Sistemic) are quoted.

“Scientists have found a possible treatment for the most common form of blindness using special stem cells found on the front surface of the eye. Research at the University of Southampton, published in the journal PLOS ONE, showed that stem cells can be gathered from the corneal limbus. This part of the eye is a narrow gap between the transparent cornea and white sclera. Under the correct conditions, these cells could be directed to behave like the cells needed to see light - photoreceptor cells.”
Inside Philanthropy: Andy Grove's philanthropy is personal, and urgent
In this article, former president, CEO, and chairman of Intel, Andrew Grove, who keynoted the 2011 World Stem Cell Summit, is profiled. He has pushed aggressively with his philanthropy including support for stem cell research. He supports and advises the Michael J. Fox Foundation seeking treatments for Parkinson’s disease.
University of Rochester: Research seeks to break new ground in understanding of Schizophrenia
“More than $6 million in funding from the National Institute of Mental Health (NIMH) is supporting new research that could fundamentally alter the way we comprehend and, perhaps ultimately, treat schizophrenia. The research – which is being led by University of Rochester Center for Translational Neuromedicine co-directors Steve Goldman, M.D., Ph.D., and Maiken Nedergaard, M.D., DMSc – will explore the role that support cells found in the brain, called glia, play in the disease.”
Stem Cell Research
Tokyo Electron launches its open innovation Stem Cell Technology Centre (STC) in the UK to develop smart cell processing technologies
According to a company media release, “Tokyo Electron Limited opened, through its European subsidiary Tokyo Electron Europe Limited (TEE), the company’s open innovation centre at Stevenage Bioscience Catalyst (SBC) in the United Kingdom. The goal is to jointly, with ecosystem partners from academia and industry, develop standardized Smart Cell Processing Technologies for cell culture and inspection through open innovation. TEL has unique experience of automation and quality management frameworks from decades of innovation and development in the semiconductor industry; it is therefore well placed to lead on the transfer of these techniques into life sciences.”
NeoStem: Company strengthens balance sheet with non-dilutive financing- reports on milestones
“This new debt facility will serve as an excellent source of non-dilutive capital to support the launch of our Intus Phase 3 clinical trial in metastatic melanoma, a significant milestone we anticipate meeting by the end of this year,” said Dr. Robin L. Smith, Chairman and CEO of NeoStem. “We are pleased both by the terms of the loan and the flexibility it offers us to meet our near-term goals.”
Stemedica secures U.S. patent to use multiple stem cell lines simultaneously to treat ischemic stroke
According to a company media release, Stemedica was issued a new patent from the U.S. Patent & Trademark entitled “Composition of Stem Cells and Stem Cell Factors for Their Use and Manufacture.” This patent covers a method for treating patients with ischemic stroke, and the treatment includes “intrathecal administration of hypoxically grown neural stem cells and intravenous administration of hypoxically grown mesenchymal stem cells.”
The Scientist: Setting the record straight- social media and science
According to Daniel Cossins of writing in The Scientist, researchers are taking to social media to challenge weak research, share replication attempts in real time, and counteract hype. Will this online discourse enrich the scientific process? This thoughtful article showcases Dr. Paul Knoepfler, PubPeer, PubMed Commons and the world of social media.
Korea Real Time (WSJ Asia): Korean cloning scandal movie examines patriotic instincts
At the time it was said that it was the greatest scientific scandal since the “Piltdown Man.” Indeed, living through the Woo Suk Hwang cloning debacle was a real wake up call to the science and stem cell advocacy communities. The “stranger than fiction” saga is now a movie in Korea- hopefully with English sub-titles. For those wanting to really understand the true story, pick up a copy of the bestselling Stem Cell Wars by Eve Herold, GPI’s former Director of Education and Public Policy. The book is easily found on Amazon.

360 Newsletter Editor

Bernard Siegel
Executive Director
Genetics Policy Institute

Stem Cells and the Transformative Power of Hope-a TEDx talk by Bernard Siegel, Editor of 360 Newsletter
Domain: Medical
Category: Biology

Recent Newsletters

12 March, 2019
10 October, 2018
15 February, 2018